We finally provided evidence to indicate that Nfe2, a transcription factor involved in normal and malignant hematopoiesis [13,14,15,16,17], could provide breast cancer cells with an advantage to grow efficiently in a bone cavity, thereby accelerating breast cancer bone metastasis. The gene discussed is NFE2; the disease is breast carcinoma.